Currently, most studies have confirmed that high serum β2-microglobulin, low albumin, high serum creatinine, high lactate dehydrogenase, low hemoglobin, low platelet count, high-risk cytogenetic abnormalities, and advanced age are adverse prognostic factors for multiple myeloma [3]. This evidence concerns the gene HLA-G and plasma cell myeloma.